The average one-year price target for Turn Therapeutics (NASDAQGM:TTRX) has been revised to $20.40 / share. This is an increase of 24.42% from the prior estimate of $16.40 dated September 11, 2026. These figures represent aggregate analyst targets and do not constitute a recomme
The average one-year price target for Eos Energy Enterprises, Inc. - Equity Right (NASDAQCM:EOSER) has been revised to $0.01 per share. This is an increase of 21.07% from the prior estimate of $0.01 dated September 13, 2026. These figures represent an aggregate o
The average one-year price target for AmpliTech Group, Inc. - Equity Right (NASDAQCM:AMPGR) has been revised to $2.88 per share, as of October 1, 2026. This represents an increase of 11.43% from the prior estimate of $2.58 dated September 13, 2026. These figures
The average one-year price target for Braskem S.A. - Depositary Receipt (NYSE:BAK) (DB:BRD) has been revised to $2.94 / share. This is a decrease of 25.51% from the prior estimate of $3.95 dated September 13, 2026. These figures represent aggregate analyst targets collected by Fi
The average one-year price target for SLM Corporation - Preferred Stock (NASDAQGS:SLMBP) has been revised to $96.92 / share. This is an increase of 15.46% from the prior estimate of $83.94 dated September 13, 2026. These figures represent the aggregate consensus